1
|
Beinart G, Gonzalez-Angulo AM, Broglio K,
Mejia J, Ruggeri A, Mininberg E, Hortobagyi GN and Valero V:
Clinical course of 771 patients with bilateral breast cancer:
Characteristics associated with overall and recurrence-free
survival. Clin Breast Cancer. 7:867–874. 2007. View Article : Google Scholar : PubMed/NCBI
|
2
|
Chen Y, Thompson W, Semenciw R and Mao Y:
Epidemiology of contralateral breast cancer. Cancer Epidemiol
Biomarkers Prev. 8:855–861. 1999.PubMed/NCBI
|
3
|
Kheirelseid EA, Jumustafa H, Miller N,
Curran C, Sweeney K, Malone C, McLaughlin R, Newell J and Kerin MJ:
Bilateral breast cancer: Analysis of incidence, outcome, survival
and disease characteristics. Breast Cancer Res Treat. 126:131–140.
2011. View Article : Google Scholar : PubMed/NCBI
|
4
|
Hartmann LC, Schaid DJ, Woods JE, Crotty
TP, Myers JL, Arnold PG, Petty PM, Sellers TA, Johnson JL,
McDonnell SK, et al: Efficacy of bilateral prophylactic mastectomy
in women with a family history of breast cancer. N Engl J Med.
340:77–84. 1999. View Article : Google Scholar : PubMed/NCBI
|
5
|
Li CI, Malone KE, Porter PL and Daling JR:
Epidemiologic and molecular risk factors for contralateral breast
cancer among young women. Br J Cancer. 89:513–518. 2003. View Article : Google Scholar : PubMed/NCBI
|
6
|
Shibahara Y, Sugawara Y, Miki Y, Hata S,
Takahashi H, Nakamura Y, Suzuki T, Ohuchi N, Tsuji I and Sasano H:
Analysis of multiple primary cancer autopsy cases associated with
breast cancer: 2002-2010. Pathol Int. 66:695–700. 2016. View Article : Google Scholar : PubMed/NCBI
|
7
|
Momoh AO, Cohen WA, Kidwell KM, Hamill JB,
Qi J, Pusic AL, Wilkins EG and Matros E: Tradeoffs associated with
contralateral prophylactic mastectomy in women choosing breast
reconstruction: Results of a prospective multicenter cohort. Ann
Surg. 266:158–164. 2017. View Article : Google Scholar : PubMed/NCBI
|
8
|
Tuttle TM, Habermann EB, Grund EH, Morris
TJ and Virnig BA: Increasing use of contralateral prophylactic
mastectomy for breast cancer patients: A trend toward more
aggressive surgical treatment. J Clin Oncol. 25:5203–5209. 2007.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Albornoz CR, Matros E, Lee CN, Hudis CA,
Pusic AL, Elkin E, Bach PB, Cordeiro PG and Morrow M: Bilateral
mastectomy versus breast-conserving surgery for early-stage breast
cancer: The role of breast reconstruction. Plast Reconstr Surg.
135:1518–1526. 2015. View Article : Google Scholar : PubMed/NCBI
|
10
|
Kamiyama H, Suzuki K, Maeda T, Koizumi K,
Miyaki Y, Okada S, Kawamura YJ, Samuelsson JK, Alonso S, Konishi F
and Perucho M: DNA demethylation in normal colon tissue predicts
predisposition to multiple cancers. Oncogene. 31:5029–5037. 2012.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Braakhuis BJ, Tabor MP, Kummer JA, Leemans
CR and Brakenhoff RH: A genetic explanation of Slaughter's concept
of field cancerization: Evidence and clinical implications. Cancer
Res. 63:1727–1730. 2003.PubMed/NCBI
|
12
|
Suzuki K, Suzuki I, Leodolter A, Alonso S,
Horiuchi S, Yamashita K and Perucho M: Global DNA demethylation in
gastrointestinal cancer is age dependent and precedes genomic
damage. Cancer Cell. 9:199–207. 2006. View Article : Google Scholar : PubMed/NCBI
|
13
|
Deng G, Lu Y, Zlotnikov G, Thor AD and
Smith HS: Loss of heterozygosity in normal tissue adjacent to
breast carcinomas. Science. 274:2057–2059. 1996. View Article : Google Scholar : PubMed/NCBI
|
14
|
Ahlquist T, Lind GE, Costa VL, Meling GI,
Vatn M, Hoff GS, Rognum TO, Skotheim RI, Thiis-Evensen E and Lothe
RA: Gene methylation profiles of normal mucosa, and benign and
malignant colorectal tumors identify early onset markers. Mol
Cancer. 7:942008. View Article : Google Scholar : PubMed/NCBI
|
15
|
Belshaw NJ, Pal N, Tapp HS, Dainty JR,
Lewis MP, Williams MR, Lund EK and Johnson IT: Patterns of DNA
methylation in individual colonic crypts reveal aging and
cancer-related field defects in the morphologically normal mucosa.
Carcinogenesis. 31:1158–1163. 2010. View Article : Google Scholar : PubMed/NCBI
|
16
|
Konishi K, Shen L, Jelinek J, Watanabe Y,
Ahmed S, Kaneko K, Kogo M, Takano T, Imawari M, Hamilton SR and
Issa JP: Concordant DNA methylation in synchronous colorectal
carcinomas. Cancer Prev Res (Phila). 2:814–822. 2009. View Article : Google Scholar : PubMed/NCBI
|
17
|
Menigatti M, Truninger K, Gebbers JO,
Marbet U, Marra G and Schär P: Normal colorectal mucosa exhibits
sex- and segment-specific susceptibility to DNA methylation at the
hMLH1 and MGMT promoters. Oncogene. 28:899–909. 2009. View Article : Google Scholar : PubMed/NCBI
|
18
|
Paun BC, Kukuruga D, Jin Z, Mori Y, Cheng
Y, Duncan M, Stass SA, Montgomery E, Hutcheon D and Meltzer SJ:
Relation between normal rectal methylation, smoking status, and the
presence or absence of colorectal adenomas. Cancer. 116:4495–4501.
2010. View Article : Google Scholar : PubMed/NCBI
|
19
|
Ushijima T: Epigenetic field for
cancerization. J Biochem Mol Biol. 40:142–150. 2007.PubMed/NCBI
|
20
|
Worthley DL, Whitehall VL, Buttenshaw RL,
Irahara N, Greco SA, Ramsnes I, Mallitt KA, Le Leu RK, Winter J, Hu
Y, et al: DNA methylation within the normal colorectal mucosa is
associated with pathway-specific predisposition to cancer.
Oncogene. 29:1653–1662. 2010. View Article : Google Scholar : PubMed/NCBI
|
21
|
Saito M, Suzuki K, Maeda T, Kato T,
Kamiyama H, Koizumi K, Miyaki Y, Okada S, Kiyozaki H and Konishi F:
The accumulation of DNA demethylation in Sat α in normal
gastric tissues with Helicobacter pylori infection renders
susceptibility to gastric cancer in some individuals. Oncol Rep.
27:1717–1725. 2012.PubMed/NCBI
|
22
|
Herrera LA, Prada D, Andonegui MA and
Dueñas-González A: The epigenetic origin of aneuploidy. Curr
Genomics. 9:43–50. 2008. View Article : Google Scholar : PubMed/NCBI
|
23
|
Kawano H, Saeki H, Kitao H, Tsuda Y, Otsu
H, Ando K, Ito S, Egashira A, Oki E, Morita M, et al: Chromosomal
instability associated with global DNA hypomethylation is
associated with the initiation and progression of esophageal
squamous cell carcinoma. Ann Surg Oncol. 21 (Suppl 4):S696–S702.
2014. View Article : Google Scholar : PubMed/NCBI
|
24
|
Rodriguez J, Frigola J, Vendrell E,
Risques RA, Fraga MF, Morales C, Moreno V, Esteller M, Capellà G,
Ribas M and Peinado MA: Chromosomal instability correlates with
genome-wide DNA demethylation in human primary colorectal cancers.
Cancer Res. 66:8462–9468. 2006. View Article : Google Scholar : PubMed/NCBI
|
25
|
Ichida K, Suzuki K, Fukui T, Takayama Y,
Kakizawa N, Watanabe F, Ishikawa H, Muto Y, Kato T, Saito M, et al:
Overexpression of satellite alpha transcripts leads to chromosomal
instability via segregation errors at specific chromosomes. Int J
Oncol. Mar 16–2018.(Epub ahead of print). doi:
10.3892/ijo.2018.4321 2018. View Article : Google Scholar : PubMed/NCBI
|
26
|
Wolff AC, Hammond ME, Hicks DG, Dowsett M,
McShane LM, Allison KH, Allred DC, Bartlett JM, Bilous M,
Fitzgibbons P, et al: Recommendations for human epidermal growth
factor receptor 2 testing in breast cancer: American Society of
Clinical Oncology/College of American Pathologists clinical
practice guideline update. J Clin Oncol. 31:3997–4013. 2013.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Reiner AS, John EM, Brooks JD, Lynch CF,
Bernstein L, Mellemkjaer L, Malone KE, Knight JA, Capanu M, Teraoka
SN, et al: Risk of asynchronous contralateral breast cancer in
noncarriers of BRCA1 and BRCA2 mutations with a family history of
breast cancer: A report from the Women's Environmental Cancer and
Radiation Epidemiology Study. J Clin Oncol. 31:433–439. 2013.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Kanda Y: Investigation of the freely
available easy-to-use software ‘EZR’ for medical statistics. Bone
Marrow Transplant. 48:452–458. 2013. View Article : Google Scholar : PubMed/NCBI
|
29
|
Kang E, Seong MW, Park SK, Lee JW, Lee J,
Kim LS, Lee JE, Kim SY, Jeong J, Han SA, et al: The prevalence and
spectrum of BRCA1 and BRCA2 mutations in Korean population: Recent
update of the Korean Hereditary Breast Cancer (KOHBRA) study.
Breast Cancer Res Treat. 151:157–168. 2015. View Article : Google Scholar : PubMed/NCBI
|
30
|
Feinberg AP and Vogelstein B:
Hypomethylation distinguishes genes of some human cancers from
their normal counterparts. Nature. 301:89–92. 1983. View Article : Google Scholar : PubMed/NCBI
|
31
|
Rebbeck TR, Friebel T, Lynch HT, Neuhausen
SL, vant Veer L, Garber JE, Evans GR, Narod SA, Isaacs C, Matloff
E, et al: Bilateral prophylactic mastectomy reduces breast cancer
risk in BRCA1 and BRCA2 mutation carriers: The PROSE Study Group. J
Clin Oncol. 22:1055–1062. 2004. View Article : Google Scholar : PubMed/NCBI
|
32
|
Bevers TB, Armstrong DK, Arun B, Carlson
RW, Cowan KH, Daly MB, Fleming I, Garber JE, Gemignani M, Gradishar
WJ, et al: Breast cancer risk reduction. J Natl Compr Canc Netw.
5:676–701. 2007.PubMed/NCBI
|
33
|
Fu Y, Zhuang Z, Dewing M, Apple S and
Chang H: Predictors for contralateral prophylactic mastectomy in
breast cancer patients. Int J Clin Exp Pathol. 8:3748–3764.
2015.PubMed/NCBI
|
34
|
Kato T, Suzuki K, Muto Y, Sasaki J,
Tsujinaka S, Kawamura YJ, Noda H, Horie H, Konishi F and Rikiyama
T: Multiple primary malignancies involving primary sporadic
colorectal cancer in Japan: Incidence of gastric cancer with
colorectal cancer patients may be higher than previously
recognized. World J Surg Oncol. 13:232015. View Article : Google Scholar : PubMed/NCBI
|
35
|
Kondratova VN, Botezatu IV, Shelepov VP
and Likhtenshtein AV: Transcripts of satellite DNA in blood plasma:
Probable markers of tumor growth. Mol Biol (Mosk). 48:999–1007.
2014.(In Russian). View Article : Google Scholar : PubMed/NCBI
|